Cite
Corrigendum to "Forsythoside A inhibits adhesion and migration of monocytes to type II alveolar epithelial cells in lipopolysaccharide-induced acute lung injury through upregulating miR-124" [TOXICOL APPL PHARM 407 (2020) 115252].
MLA
Lu, Zi-bin, et al. “Corrigendum to ‘Forsythoside A Inhibits Adhesion and Migration of Monocytes to Type II Alveolar Epithelial Cells in Lipopolysaccharide-Induced Acute Lung Injury through Upregulating MiR-124’ [TOXICOL APPL PHARM 407 (2020) 115252].” Toxicology & Applied Pharmacology, vol. 409, Dec. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.taap.2020.115328.
APA
Lu, Z., Liu, S., Ou, J., Cao, H., Shi, L., Liu, D., Tian, C., Zheng, Y., Zhou, H., Liu, J., & Yu, L. (2020). Corrigendum to “Forsythoside A inhibits adhesion and migration of monocytes to type II alveolar epithelial cells in lipopolysaccharide-induced acute lung injury through upregulating miR-124” [TOXICOL APPL PHARM 407 (2020) 115252]. Toxicology & Applied Pharmacology, 409, N.PAG. https://doi.org/10.1016/j.taap.2020.115328
Chicago
Lu, Zi-bin, Shan-hong Liu, Jin-ying Ou, Hui-hui Cao, Ling-zhu Shi, Dong-yi Liu, Chun-yang Tian, et al. 2020. “Corrigendum to ‘Forsythoside A Inhibits Adhesion and Migration of Monocytes to Type II Alveolar Epithelial Cells in Lipopolysaccharide-Induced Acute Lung Injury through Upregulating MiR-124’ [TOXICOL APPL PHARM 407 (2020) 115252].” Toxicology & Applied Pharmacology 409 (December): N.PAG. doi:10.1016/j.taap.2020.115328.